Skip to content
Search our Site
Search our site
Search our site
My PD Journey
About the EPDA
Political affairs and policy
Medical and pharmaceutical
Political and policy
World PD Day News
Resources and publications
Cognition and Parkinson's Disease: the Patient Perspective
The Parkinson Alliance conducted a survey to examine how individuals with Parkinson's disease perceive cognition changes.
20 October 2016
BIAL launches ONGENTYS (opicapone) a novel treatment for Parkinson´s disease patients with motor fluctuations in the UK
ONGENTYS (opicapone) was authorised by the European Commission in June 2016 as an adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors (DDCIs) in adult patients with Parkinson's disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
17 October 2016
Asceneuron receives grant from The Michael J. Fox Foundation for Parkinson's research
Asceneuron SA, an emerging leader in the development of innovative small molecules for neurodegenerative diseases, today announced it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) for the further development of positive allosteric modulators of the M1 muscarinic acetylcholine receptor (M1 PAMs). M1 PAMs induce a change in the shape of the receptor, enhancing binding to the neurotransmitter acetylcholine.
06 October 2016
Association Parkinson's and Us - Move Against Parkinson's event
Read all about Move against Parkinson - a national event Association Parkinson's and Us is organising on 1st October in Croatia
29 September 2016
GLNT and UCB collaborate on wearable tech & data visualisation tools for treating Parkinson's disease
Great Lakes NeuroTech today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson's Disease and their clinicians with improved quantitative tools for assessing the impact of their current treatment with the aim of providing better individual patient experiences and, ultimately, improving quality of life.
26 September 2016
NeuroDerm to present ND0612 data at 4th World Parkinson Congress demonstrating ease of use of mini-pump delivery system
NeuroDerm Ltd., today announced that the Company will present previously unreported human factors data from a usability study focused on the interactions between Parkinson's disease patients and the mini-pump device used to administer ND0612, the Company's continuous, subcutaneously delivered levodopa/carbidopa (LD/CD) liquid formulation.
19 September 2016
Acorda launches The Many Faces of OFF Facebook page to support Parkinson's community
Acorda Therapeutics, Inc. has launched a new community resource for people with Parkinson's, The Many Faces of OFF Facebook page. The site, which is going live in conjunction with the upcoming 4th World Parkinson Congress (WPC).
15 September 2016
Perkorsi The roads of Parkinson's, to talk about Parkinson's throughout Italy.
Perkorsi is a national tour with several open meetings, organised by Parkinson Italia, to highlight the experience of people with Parkinson's, carers and volunteering associations in bringing added value and good practices to the treatment of the condition.
14 September 2016
Association Parkinson's and Us - Move Against Parkinson's Unity Walk
Read all about Move against Parkinson - a national event Association Parkinson's and Us held on 1st October in Croatia
04 September 2016
The Finnish Parkinson Association Unity Walk
Read all about the upcoming Parkinson's Unity Walk the Finnish Parkinson Association is organising on 24th September 2016.
24 August 2016
Subscribe to this page >
Back to Top
Add page to PDF basket
Copyright © 2016 EPDA. All Rights Reserved.
Privacy and cookies